SenesTech reports Q4 revenue up 70% YoY, gross margin 61%, launches $2M cost reduction plan

SenesTech, Inc.

Q4 revenue $501K, +70% YoY; gross margin 60.9% (vs 43.7%); net loss $1.3M (vs $1.7M).
Adjusted EBITDA loss narrowed to $1.1M from $1.6M; cash $1.3M at year-end, raised ~$2M in Q1 2025.
New operating optimization targets $2M annual expense reduction; cash flow breakeven now at ~$7M revenue (was $12M).
Evolve Rat and Evolve Mouse products drove 52% and 24% of Q4 revenue respectively; NYC pilot order received.
International expansion: distribution agreements in 10 countries; shipments to Hong Kong, UAE, Netherlands, Maldives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.